Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 991 | 1,801 | 1,458 | 18,742 | 1,197 |
| Operating Income | -991 | -1,801 | -1,458 | -13,630 | -1,197 |
| Other Income | 68 | -241 | 259 | -536 | 278 |
| Pre-tax Income | -923 | -2,041 | -1,200 | -14,166 | -920 |
| Net Income Continuous | -923 | -2,041 | -1,200 | -14,166 | -920 |
| Net Income Discontinuous | N/A | 14,948 | -2,121 | N/A | -2,602 |
| Net Income | $-923 | $12,907 | $-3,321 | $-4,381 | $-3,522 |
| EPS Basic Total Ops | -0.03 | -1.29 | -9.37 | -15.41 | -16.65 |
| EPS Basic Continuous Ops | -0.03 | -1.58 | -8.46 | 3.26 | -13.34 |
| EPS Basic Discontinuous Ops | N/A | 0.29 | -0.91 | N/A | -3.31 |
| EPS Diluted Total Ops | -0.03 | -1.29 | -9.37 | -15.41 | -16.65 |
| EPS Diluted Continuous Ops | -0.03 | -1.58 | -8.46 | 3.26 | -13.34 |
| EPS Diluted Discontinuous Ops | N/A | 0.29 | -0.91 | N/A | -3.31 |
| EPS Diluted Before Non-Recurring Items | -0.03 | -1.58 | -8.46 | -29.00 | -13.25 |
| EBITDA(a) | $-991 | $-1,801 | $-1,458 | $-18,742 | $-1,197 |